Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07JNQ
|
||||
Former ID |
DNC007107
|
||||
Drug Name |
NSC-73410
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528457] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H10N2O7S
|
||||
Canonical SMILES |
C1=CC(=C2C(=C1N)C(=O)C3=C(C2=O)C(=CC(=C3O)S(=O)(=O)O)N)<br />O
|
||||
InChI |
1S/C14H10N2O7S/c15-4-1-2-6(17)10-8(4)14(20)11-9(13(10)19)5(16)3-7(12(11)18)24(21,22)23/h1-3,17-18H,15-16H2,(H,21,22,23)
|
||||
InChIKey |
SPHQXPPVJCWUGX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [528457] | |
KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
PathWhiz Pathway | Vitamin K Metabolism | ||||
WikiPathways | Estrogen metabolism | ||||
Oxidative Stress | |||||
Transcriptional activation by NRF2 | |||||
NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Aryl Hydrocarbon Receptor Pathway | |||||
Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
Metabolism of amino acids and derivatives | |||||
Aryl Hydrocarbon Receptor | |||||
Dopamine metabolism | |||||
Arylhydrocarbon receptor (AhR) signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.